News
Featured News
First Ever MRI Device in American Samoa
Dr. James E. Galvin, who has been conducting research alongside the American Samoa Cancer Community Coalition in the onsite on Alzheimer’s Disease, assisted in introducing the First Ever MRI Device in the American Samoa!
Researchers find that as Americans live longer the risk of developing dementia will dramatically increase.
2/18/26. About a million Americans a year are expected to develop dementia by 2060, roughly double today’s toll, researchers reported in January.
Cognition Therapeutics Extends Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies.
2/5/26. Cognition Therapeutics, Inc., a clinical-stage company developing drugs that treat neurodegenerative disorders, has extended the duration of the expanded access program (EAP) for dementia with Lewy bodies (DLB). The program, which was originally expected to provide each participant with twelve months of treatment, will now allow several more months of treatment.
Cognition Therapeutics Publishes Phase 2 Clinical Results Showing Zervimesine’s Potential to Slow the Progression of Dementia with Lewy Bodies.
1/6/26. Zervimesine exhibited meaningful improvement in behavioral, functional, cognitive, and movement measures compared to placebo
American Neurology Summit 2025 Achieves Major Success With Full Attendance and High Engagement!
11/15 – 11/16/25. ANS2025 served as a national platform for neurologists, primary care clinicians, nurses, and researchers to engage in high-impact education on the latest advancements in neurological care. Dr. Galvin discussed biomarkers, cognitive assessment tools such as the AD8 and QDRS, and evolving diagnostic pathways.
“You can take control of your brain health,” Galvin says.
10/28/2025. “There is a cumulative effect of things we can do to mitigate our risk for Alzheimer’s disease,” Galvin says. “Stop smoking, eat healthy and exercise. Cumulatively, setting these intentions can make a big difference in our lives.”
CervoMed Highlights Neflamapimod's Potential Benefits in Session on Dementia with Lewy Bodies at the 150th Annual American Neurology Association Conference.
9/13 – 9/16/25. CervoMed Inc., a clinical stage company focused on developing treatments for age-related neurologic disorders, announced the promising development program and potential benefits of neflamapimod for the treatment of Dementia with Lewy Bodies (DLB). Dr. Galvin presented information on the advances in drug development for DLB.
Cognition Therapeutics presented findings at AAIC.
7/29/25. Cognition Therapeutics presents data at AAIC highlighting broad neurological impact of Zervimesine (CT1812) in Dementia with Lewy Bodies and Alzheimer’s Disease.
Overviewing the Clinical Use of the CARM Score in Alzheimer Disease Detection
7/17/25. Neurology Live interview with Dr. James E. Galvin on the clinical use of Cognivue Amyloid Risk Measure in the context of Alzheimer disease care (video 3:01).
7/12-7/16/25. Dr. James E. Galvin, Dr. Lilah Besser with her ‘Neighborhood Built Environment’ poster, and Dr. Michael Kleinman with his ‘Puppy Escape’ poster at the AAIC 2025.
CCBH Influence by the Numbers in 2024
Dr. James E. Galvin, MD, MPH and Department of Neurology Research Faculty at the University of Miami’s Comprehensive Center for Brain Health earned widespread attention for their efforts and impact on dementia risks, treatments, and prevention discussed in news stories and featured interviews on television, radio, and print sources. The CCBH coverage in 2024 reached global audiences throughout North America, Europe, Russia, Singapore and India spanning dozens of radio stations, hundreds of online news portals, 167+ media mentions, an estimated audience reach of over 848 million, and more than 1 million broadcast views. The prominent news and media sources include The Associated Press, CNN, Fox News, Healio, Sun-Sentinel, WLRN, Yahoo! News, MSN, WIOD/iHeart Radio, Ivanhoe News, and The Baltimore Sun.
2023 - 2024 News
American Academy of Neurology Continuum
12/11/24. Allison Weathers, MD, FAAN, speaks with James E. Galvin, MD, MPH, author of the article “Lewy Body Dementia,” (Podcast 23:50)
Yahoo! News. WJET Health Report
9/30/24. New treatment discovered for Lewy Body Dementia with Dr. James E. Galvin, MD (2-min read).
Alzheimer's Association International Conference 2024
8/19/24. UM Multidisciplinary Alzheimer’s researchers offer new insights. CCBH Presenters at the conference (17-min read).
Interview at Alzheimer's Assoc Int'l Conf 2024
7/30/24. AAIC24 interviews Dr. James E. Galvin MD discussing blood biomarkers and Alzheimer’s disease (video 1:21).
Fox News. Good body composition can build a better brain
7/30/24. Interview with Dr. James E. Galvin. Muscle mass loss and visceral fat increase are risk factors for cognitive impairment (4-min read).
CBS News. A new Alzheimer's drug gained FDA approval
7/2/24. Interview with Dr. James E. Galvin, MD. The drug Donanemab soon to hit the market as a treatment, not a cure (video 3:32 min).
WFMZ-TV. News Health Beat: Don't drink your way to disease
6/21/24. Interview with Dr. James E. Galvin, MD on alcohol consumption and dementia risks (2-min read).
WJAR-TV. Health Check
5/3/24. Brain Health interview with Dr. James E. Galvin on healthy brain lifestyle practices to aid in dementia prevention (video 2:00).
PBTV and PB Civic Association Report.
2/25/24. Health Care Committee presents “Committees at work: Understanding Dementia” (video 17:25).
CNN Health Report on Alzheimer's
1/29/24. Multi-neurologists interview discussing the recent publication findings of rare cases of possible Alzheimer’s transmission (6-min read).
Research and Innovation
11/17/23. $3 Million Grant Spurs Research into Alzheimer’s Disease in Indigenous Populations (5-min read).
McKnight News. Green space exposure and brain health
10/27/23. Interview with Dr. Lilah Besser, PhD discussing how social determinants of health impact cognition and how green space can reduce risks (4-min read).
Research and Innovation
10/25/23. “Greenspace and income levels may affect brain and health” with Dr. Lilah M. Besser, PhD (3-min read).
Palm Beach Post. CCBH Health Symposium
10/17/23. UM Faculty Dr. James E. Galvin, MD, Dr. Michael J. Kleiman, Dr. Lilah Besser, PhD, and Dr. Deirdre O’Shea presenting at CCBH Hot Topics in Brain Health Fall Conference (5-min read).
Grants and Awards
3/8/23. Dr. James e. Galvin Receives Alexandria and Bernard Schoninger Endowed Chair in Memory Disorders (4-min read).
